Rabeprazole For Injection 20mg Dry Powder Injections Vial

Rabeprazole For Injection 20mg Dry Powder Injections Vial

Product Name :

Voriconazole Injection IP 200 Mg

Available Strength :

200 mg

Packing :

Vial / As per your requirement

Pack Insert/ Leaflet :

Available upon request

Therapeutical Use :

Antifungal

Production Capacity :

Available on request

Description:

What is Rabeprazole For Injection 20mg?

Rabeprazole For Injection 20mg is specified as a dry powder injectable formulation containing rabeprazole, a proton pump inhibitor (PPI) that reduces gastric acid secretion. The availability and approved use of an injectable rabeprazole formulation should be verified for the intended market. Product-specific indications, preparation requirements and administration instructions must be confirmed against the approved product documentation.

Uses and Indications

Rabeprazole reduces gastric acid secretion by inhibiting the gastric proton pump. However, its established uses in oral formulations should not automatically be applied to this injectable product.

Potential therapeutic use must be determined by the approved injectable product information, including:

  • The authorised clinical indications.

  • Whether parenteral administration is approved for the intended market.

  • The circumstances in which injectable treatment is appropriate.

The injectable formulation, approved indications and route of administration require verification before this listing is used as a definitive clinical description.

Potential Benefits

  • Gastric acid suppression: Rabeprazole inhibits the gastric proton pump.

  • Specified strength: The supplied product strength is 20mg.

  • Injectable presentation: The stated dosage form is dry powder injection; formulation details require confirmation.

  • International sourcing support: Kelar Pharmachem India supports pharmaceutical sourcing and export enquiries for international buyers.

Side Effects

Adverse effects reported with rabeprazole products may include:

Commonly reported effects

  • Headache

  • Abdominal discomfort

  • Nausea

  • Diarrhoea or constipation

Potentially serious effects

  • Severe allergic reactions

  • Significant skin reactions

  • Persistent or severe diarrhoea

  • Signs of liver problems

The adverse-effect profile and monitoring requirements for the specified injectable formulation must be checked against its approved product information.

How Does Rabeprazole Work?

Rabeprazole inhibits the hydrogen-potassium ATPase enzyme, commonly called the gastric proton pump. This enzyme participates in the final stage of stomach acid secretion. By inhibiting its activity, rabeprazole reduces acid production. The relevance of this mechanism to the supplied injectable formulation does not establish its approval or suitability for any particular indication.

Dosage Guidelines

  • Supplied strength: 20mg.

  • Dose, frequency and treatment duration must follow the approved product information.

  • Preparation and administration must follow the instructions specific to the injectable formulation.

  • Use should be directed by a qualified healthcare professional.

Do not infer the diluent, reconstitution volume, route, infusion rate or stability after preparation from the strength alone. Confirm these details against the approved product documentation.

When Not to Use

Rabeprazole may be unsuitable for patients with:

  • Known hypersensitivity to rabeprazole, substituted benzimidazoles or any formulation component.

  • A contraindication stated in the approved product information.

  • A clinical situation in which the treating healthcare professional considers an alternative treatment more appropriate.

Allergy history, relevant medical conditions and concomitant medicines should be reviewed before use.

Drug and Product Interactions

Rabeprazole may interact with medicines whose absorption depends on gastric acidity or whose metabolism may be affected by acid-suppressing therapy.

Medicines requiring review may include:

  • Certain antiretroviral medicines.

  • Warfarin and other medicines requiring clinical monitoring.

  • Methotrexate, particularly at high doses.

  • Other medicines with product-specific interaction warnings.

A healthcare professional should review all concurrent medicines. Drug interactions are distinct from physical compatibility; do not mix this product with other injectable medicines unless compatibility has been verified for the specific products and preparation conditions.

Safety Advice

  • Verify that the supplied injectable formulation is approved for the intended market and indication.

  • Confirm product identity, strength and preparation instructions before administration.

  • Inform the healthcare professional about allergies and current medicines.

  • Monitor for adverse reactions as directed by the treating team.

  • Do not use a vial if its packaging or product identification is compromised.

General Instructions

  • Follow the approved product label and manufacturer’s preparation instructions.

  • Use only the specified diluent and administration method when confirmed by product documentation.

  • Do not mix with other injectable medicines without verified compatibility information.

  • Observe the approved handling and in-use requirements.

  • Confirm all product-specific details against the approved product specification.

Special Dietary and Lifestyle Tips

For patients being treated for an acid-related condition, general measures may include:

  • Follow dietary guidance appropriate to the underlying diagnosis.

  • Consider smaller meals if large meals aggravate symptoms.

  • Identify individual food or drink triggers where relevant.

  • Avoid smoking and excessive alcohol consumption where appropriate.

  • Seek medical assessment for persistent or worsening gastrointestinal symptoms.

Lifestyle measures do not replace prescribed treatment.

Comparison with Other Treatments

Treatment General characteristics
Rabeprazole Proton pump inhibitor that reduces gastric acid secretion; the stated injectable formulation requires product-specific verification.
Pantoprazole Another proton pump inhibitor available in injectable formulations in some markets.
Omeprazole Proton pump inhibitor used for approved acid-related conditions in relevant formulations.
H2-receptor antagonists Reduce gastric acid secretion through a different mechanism.
Antacids Neutralise existing stomach acid and are used for symptom relief in suitable circumstances.

These treatments are not automatically interchangeable. Selection depends on the approved formulation, clinical indication, patient factors and local prescribing guidance.

Precautions and Warnings

  • Verify the existence, formulation and regulatory status of the specified injectable product in the target market.

  • Do not assume that indications for oral rabeprazole apply to an injectable formulation.

  • Review allergy history and potential drug interactions.

  • Follow product-specific preparation, administration and monitoring requirements.

  • Do not publish unverified claims about approvals, certifications or manufacturing facilities.

  • Product details should be confirmed against the approved product specification.

Can I Use It With Other Medicines or Antibiotics?

Rabeprazole may be used alongside other medicines when clinically appropriate, but suitability depends on the treatment regimen and product-specific information.

  • Have a qualified healthcare professional review all current medicines.

  • Do not mix injectable products without verified compatibility.

  • Use antibiotics only when prescribed for an appropriate clinical indication.

  • Confirm the approved injectable formulation and relevant prescribing instructions before describing specific combination regimens.

Storage

Store according to the approved product label and manufacturer’s instructions. The storage temperature, light-protection requirements, shelf life after reconstitution and in-use stability period have not been supplied and should not be assumed.

Frequently Asked Questions

1. What is Rabeprazole For Injection 20mg?

The supplied product description identifies a 20mg dry powder injectable formulation containing rabeprazole, a proton pump inhibitor. The injectable formulation should be verified against approved product documentation.

2. What is the stated strength?

The supplied strength is 20mg.

3. What is the dosage form?

The supplied dosage form is dry powder injection in a vial.

4. What is rabeprazole used for?

Rabeprazole reduces gastric acid secretion. The approved indications for this specific injectable formulation must be confirmed separately.

5. Who should prepare and administer this product?

A qualified healthcare professional should follow the approved product-specific preparation and administration instructions.

6. What are the storage requirements?

Refer to the approved product label and specification. A specific storage temperature has not been provided.

7. Can international buyers enquire through Kelar Pharmachem India?

Kelar Pharmachem India supports pharmaceutical sourcing and export enquiries. Product availability, packing, documentation and supply terms can be confirmed on request.

Scroll to Top